anmelden
Analysen von Richard Vosser
| 21.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.04.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 20.04.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 10.04.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 10.04.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 07.04.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 07.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 31.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.03.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.03.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 30.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.03.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 25.03.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 18.03.26 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 18.03.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 17.03.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 16.03.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 12.03.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.03.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 09.03.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.03.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 06.03.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 05.03.26 | arGEN-X Overweight | JP Morgan Chase & Co. | |
| 05.03.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 04.03.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 04.03.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 02.03.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 02.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.02.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 24.02.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.02.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 18.02.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 17.02.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 12.02.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 12.02.26 | Novartis Overweight | JP Morgan Chase & Co. | |
| 11.02.26 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 10.02.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.02.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.02.26 | Merck Overweight | JP Morgan Chase & Co. | |
| 06.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 04.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.02.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 30.01.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
